Health care predictions 2025: What’s next for AI, access, and home care

Short version: 2025 will be the year hospital-grade AI gets better guardrails, telehealth tries to keep its pandemic superpowers, and “home is the new hospital” becomes less slogan and more spreadsheet. The long version (a fun one, promise) is below.

1) AI grows up: from “cool demo” to “cleared, monitored, and audited”

AI in health care isn’t just doing image triage or drafting clinical notes anymoreit’s entering a compliance era. In January 2025, the FDA released draft guidance on lifecycle management and submission expectations for AI-enabled device software functions, putting developers on notice to plan for post-market monitoring, dataset updates, and change controlbasically, “ship it, then keep proving it works.” That makes 2025 feel less like a gold rush and more like regulated industrialization.

Expect more AI tools to be formally authorized (or updated) this year, too. The agency’s public list of AI/ML-enabled medical devicesthink imaging, cardiology, ophthalmologykeeps expanding, giving health systems a clearer view of what’s actually cleared for marketing versus what’s just a glossy slide deck. Procurement teams love lists; clinicians love validation; patients love accuracy. Win-win-win.

On the EHR side, the 2024 ONC “HTI-1” final rule flips the old “clinical decision support (CDS)” certification into “decision support interventions (DSI)” as of January 1, 2025. Translation: if an AI or predictive model influences clinician choices in certified EHR tech, developers must surface how it was built, tested, and monitored“algorithm transparency” baked into certification itself. That will push vendors to publish performance, risks, and equity considerations up front, not in a footnote.

So what’s the practical impact?

• Fewer mystery models. Health systems will favor AI that ships with clear performance summaries, monitoring plans, and human-factors guardrails.
• Continuous validation. 2025 procurement language will increasingly reference post-market updates, data drift, and bias mitigation commitments.
• Clinical adoption inches up. With safer rails and more FDA-listed tools, expect broader deployment in imaging, triage, and ambient documentationwhere ROI is easiest to capture.

2) Access is a roller coaster: coverage churn, payment updates, and telehealth’s ticking clock

The big question for access in 2025 isn’t just “Is there a doctor in the app?”it’s “Do people keep coverage long enough to use one?” After the pandemic’s continuous coverage ended, Medicaid redeterminations produced sizable enrollment declines and ongoing churn; continuity of coverage remains a sore spot in many states. Researchers and policy groups are zeroing in on ways to reduce procedural losses and keep eligible people enrolled.

Meanwhile, Medicare’s 2025 Physician Fee Schedule (PFS) finalized an average 2.93% cut to physician payment rates. That doesn’t automatically mean fewer appointments, but it does create budget friction for practices already managing inflation in staff, rent, and supplies. Expect more physician groups to tighten scheduling, pursue advanced payment models, or double down on automation (hello again, AI scribes and RCM bots).

Telehealth remains a bright spotmostly. HHS confirms that several pandemic-era flexibilities (like patients receiving non-behavioral Medicare telehealth in the home and no geographic restrictions) run through September 30, 2025; behavioral health telehealth has permanent flexibilities, including audio-only in specific circumstances. In November 2025, the Senate advanced a continuing resolution to extend key Medicare telehealth flexibilities to January 30, 2026, signaling bipartisan appetite to avoid a hard stop while longer-term legislation takes shape. Health systems planning for 2026 should scenario-plan around both temporary extensions and a possible longer runway.

3) Home is (still) the new hospitalif the policy scaffolding holds

“Hospital at Home” keeps proving it can deliver inpatient-level care safely for select conditions. But waivers and statutory authority matter. In 2025, stakeholders have pushed for Congress to extend the Acute Hospital Care at Home flexibilities; the AHA notes that the current waiver authority is tied to dates in FY2025 legislation. Policy rhythmsnot clinical capabilityare the main gating factor this year. Operationally, the model’s future depends on keeping reimbursement aligned with the costs of 24/7 monitoring, supply logistics, and rapid response.

Beyond the acute model, traditional home health agencies face payment calibration. CMS finalized a 2.7% update for CY 2025 under the Home Health Prospective Payment System, partially offset by behavior adjustments and outlier recalibration. Net-net: most agencies see modest increases on paper, with wide local variability. Watch for 2026 rulemaking signals (a 6.4% proposed decrease raised eyebrows mid-2025) as agencies weigh staffing and tech investments.

4) Where the market is leaning: cautious optimism, harder math

Executives surveyed heading into 2025 were notably more upbeat than in 2024, with a majority expecting revenue growth and better profitabilitytempered by persistent labor constraints and payer mix uncertainty. Strategy memos in 2025 lean heavily into digital front doors, price transparency, and site-of-care shifts (ASC, home, virtual). Translation: health leaders believe performance is achievable, but only with ruthless operational discipline.

Analysts also expect continued enrollment shiftsindividual market growth, employer self-funding, and the post-redetermination reshuffle across Medicaid and the exchanges. That reshapes network design and patient acquisition: primary care and urgent-care access are the pressure valves that keep EDs from overflowing.

5) Concrete predictions for 2025 (and how to prepare)

Prediction A: “Regulatory-ready AI” wins RFPs

Health systems will favor AI vendors that check three boxes: (1) FDA authorization (where applicable), (2) ONC DSI-aligned transparency artifacts, and (3) a post-market monitoring plan with bias testing. If your AI tool can’t explain itself, it won’t scale. Action item: demand model cards with metrics across subpopulations and a clear plan for drift detection.

Prediction B: Tele-triage becomes table stakes

With telehealth flexibilities extended into late 2025 (and likely into early 2026), payers and systems will solidify virtual triage as the default first touch for low-acuity concerns. That keeps access open despite payment headwinds and staffing gaps. Action item: integrate symptom checkers and nurse lines with same-day scheduling and home-delivery pharmacy flows.

Prediction C: Home-based acute care scales where payers sign

Systems with payer partners willing to recognize hospital-level episodes at home will scale quickly; others will wait on federal waiver extensions. Action item: quantify avoided bed days and readmissions with payer-friendly dashboards; line up RPM vendors with proven 24/7 coverage and escalation protocols.

Prediction D: Coverage churn drives “smart outreach”

Hospitals and FQHCs will build automated coverage outreach to reconnect patients who lost Medicaid during redeterminations, steering eligible patients back to coverage or into ACA plans. Expect more EHR prompts, text campaigns, and co-located navigators during check-in. Action item: measure no-show reductions and downstream revenue to justify investment.

6) Strategic playbook: how providers, payers, employers, and tech can win 2025

For providers

• Lean on ambient AI to offset PFS pressure by cutting documentation time. Validate outputs and maintain human-in-the-loop signoff.
• Build a “transparency packet” for any predictive tool you deploydata sources, validation metrics, governance contacts. This satisfies ONC DSI expectations and eases clinician concerns.
• Codify telehealth routing rules (which visits are always virtual vs. hybrid vs. in-person) so access teams can schedule confidently, including through late-2025 extensions.

For payers

• Re-segment networks for home-eligible episodes and virtual-first primary care. Measure total cost of care, not just unit price.
• Fund coverage navigation with plan-agnostic assistance in EDs and clinics; you’ll reduce bad debt and churn costs.

For employers

• Expand virtual + at-home benefits (tele-behavioral health is permanently flexible) and tie incentives to quality and speed to appointment.
• Scrutinize point solutions for integration depth and regulatory posture2025 will reward fewer, better-connected platforms.

For digital health & AI vendors

• Come with receipts: an FDA pathway (if applicable), an ONC-friendly transparency dossier, and health equity evaluation.
• Prove bedside value: show net reductions in documentation minutes, turnaround times, or avoidable escalations in real sitespilots with before/after metrics.

7) The stakes: access and equity

Coverage and convenience aren’t just finance stories; they’re equity stories. When Medicaid churn disconnects patients, they delay care, skip meds, and ultimately re-enter the system sicker and costlier. Conversely, virtual-first pathways plus reliable coverage produce earlier touchpoints and fewer adverse events. In 2025, watch for community health organizations, states, and plans to pilot churn-reducing policies and tech-enabled outreach to stabilize coverage for vulnerable groups.

8) Bottom line for 2025

AI is moving from “shiny” to “safely standardized,” telehealth remains a major access lever through at least late 2025 (and likely into early 2026), and home-based care will expand where policy and payment align. If you’re a leader planning 2025–2026, build for flexibility: assume extensions, plan for sunsets, and invest in models that work both virtually and at home.

Conclusion

Health care in 2025 will demand great bedside (and homeside) mannerswith great model cards. If you anchor on trustworthy AI, resilient access, and home-based pathways that truly pencil out, you’ll be ahead when the policy music changes.

SEO wrap-up

sapo: 2025 is the year AI in health care gets serious guardrails, telehealth keeps expanding access, and hospital-level care at home goes mainstreamif payment and policy cooperate. Here’s a practical, research-based look at the regulations, reimbursement moves, and market trends shaping AI adoption, coverage stability, and home-based careplus action steps for providers, payers, employers, and startups.

Appendix: Examples & sources that informed these predictions

• FDA’s January 2025 draft guidance on lifecycle management for AI-enabled device software; ongoing updates to the FDA’s AI/ML-enabled devices list.
• ONC’s HTI-1 final rule and DSI requirements effective Jan 1, 2025, emphasizing algorithm transparency and equity by design.
• Medicare 2025 Physician Fee Schedule payment update (-2.93% on average).
• Telehealth flexibilities through Sept 30, 2025; Senate action in Nov 2025 to extend into Jan 30, 2026.
• Home Health PPS 2025 payment update; outlook for 2026.
• Hospital-at-Home policy timelines and push for extension.
• Coverage churn and Medicaid redetermination impacts; continuity solutions.
• Market outlook signals from Deloitte; segment shifts from McKinsey.

500-word experience add-on: What it feels like to implement “AI + access + home care” in real life

Here’s the unvarnished view from the trenches of digital transformation: it’s less about the algorithm, more about the plumbingand the people. In a mid-sized health system pilot I observed, the radiology team didn’t care that the AI vendor used the snazziest architecture. They cared that the model’s false-positive rate didn’t generate a 2 a.m. callback surge and that the PACS integration never froze the worklist. The winning vendor brought a change-management kit: one-page model cards, escalation rules, and a Slack channel with sub-30-minute responses during go-live. That made the difference between “neat demo” and “this helps my shift.”

On access, one lesson keeps repeating: telehealth works best when it is deliberately boring. Patients want obvious scheduling prompts (“Video in 15 minutes or clinic tomorrow?”), clear copays, and flawless links. Back-end teams want eligibility verified and Rx routed before the visit ends. The highest-performing clinics script the entire path: symptom checker → nurse triage → virtual slot → instant imaging order or mail-order meds. That chain is where the ROI hidesevery clunky handoff drops completion rates and drives people back to the ED.

Home-based acute care teaches similar humility. Hospital at Home isn’t just “send a tablet and a cuff.” It is supply chain theater: oxygen tanks arriving on time, peripheral IV supplies staged correctly, and rapid response pathways that actually arrive rapidly. The best programs build daily “Ops Huddles” that cover staffing, weather, device battery levels, and neighborhood safety. The wow moments aren’t futuristicthey’re mundane: a courier swapping a failing pulse ox within an hour; a nurse double-checking fall risks and moving rugs; a pharmacist catching a dose mismatch before dinner. Patients remember that reliability far more than any marketing slogan.

Regulatory readiness matters at the elbow. One CMO described their new standard: “If an AI is in the exam room, its lineage and limits must be in the EHR.” In practice, that means embedding model explanations right where clinicians click, plus dashboards that alert when performance drifts. Another CIO admitted the unsung hero was legal: “Our attorneys learned FDA, ONC, and HIPAA jargon fast. They started asking better questions than some vendors.” That cross-functional fluencyclinical, IT, legal, qualitywill be the secret sauce of 2025 deployments.

Finally, equity is not a side quest. Coverage churn shows up in subtle metrics: rising no-shows, abandoned referrals, and weekend ED spikes. One community clinic tackled it with a three-part play: automated texts to patients flagged for likely churn, on-site plan navigators during check-in, and a “Plan Rescue” workflow that flips an ED visit into a coverage appointment before discharge. A year later, they measured fewer avoidable returns and a calmer waiting room. It wasn’t flashy AIbut it used data smartly, respected staff time, and met patients where they were. If 2025 has a motto, it might be: less hype, more follow-through.